TLR Ligand Matured Dendritic Cell Vaccination in Melanoma Patients: the Key Towards a More Potent Immune Induction?
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melanoma vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 17 Apr 2017 Biomarkers information updated
- 07 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jul 2009 New trial record